Previous close | 2.0000 |
Open | 2.0000 |
Bid | 3.7000 |
Ask | 3.9000 |
Strike | 5.00 |
Expiry date | 2024-06-21 |
Day's range | 2.0000 - 2.0000 |
Contract range | N/A |
Volume | |
Open interest | 62 |
Despite robust revenue growth and product expansion, Augmedix faces downward adjustments in annual revenue forecasts and increased operational losses.
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. “Augmedix delivered in-line first quarter performance, with 40% revenue growth, 143% net revenue retention and 47.1% gross margins,” commented Manny Krakaris, Augmedix CEO. “We are confident about our positioning within the medical documentation market, and expect to report continued g